BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22032835)

  • 1. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
    Jiang X; Morland SJ; Hitchcock A; Thomas EJ; Campbell IG
    Cancer Res; 1998 Apr; 58(8):1707-12. PubMed ID: 9563487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
    Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
    Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
    Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
    Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
    Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; AbrĂ£o MS
    J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2011 Oct; 123(1):157-63. PubMed ID: 21742370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
    Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
    Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometriosis and ovarian cancer: a review.
    Vlahos NF; Kalampokas T; Fotiou S
    Gynecol Endocrinol; 2010 Mar; 26(3):213-9. PubMed ID: 19718562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
    Canet B; Pons C; Espinosa I; Prat J
    Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic changes between endometriosis and ovarian cancer.
    Obata K; Hoshiai H
    Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W; Awadallah A; Xin W
    Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma.
    Otsuka J; Okuda T; Sekizawa A; Amemiya S; Saito H; Okai T; Kushima M; Tachikawa T
    Med Electron Microsc; 2004 Sep; 37(3):188-92. PubMed ID: 15449112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometriosis and ovarian cancer: clinical and molecular aspects.
    Pavlidou A; Vlahos NF
    Minerva Endocrinol; 2014 Sep; 39(3):155-65. PubMed ID: 25003226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
    J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.